HER2 heterogeneity in adenocarcinoma of the distal esophagus and stomach.

Rogier Butter,Gerrit K. J. Hooijer,Myrtle van der Wel,Jos Bart,Susan Ter Borg,Loes van Velthuysen,Marc J. van de Vijver

HER2 heterogeneity in adenocarcinoma of the distal esophagus and stomach.

2020

Rogier Butter
Gerrit K. J. Hooijer
Myrtle van der Wel
Jos Bart
Susan Ter Borg
Loes van Velthuysen
Marc J. van de Vijver

4567Background: Patients with HER2 positive adenocarcinoma of the esophagus or stomach are eligible for HER2 targeted therapy, which can improve survival in selected patients. Previous research sho...

Keywords:

Medicine
Adenocarcinoma
Stomach
Pathology
distal esophagus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations